Arich Enterprise Co., Ltd. (TPEX:4173)
17.95
-0.10 (-0.55%)
Jul 14, 2026, 1:24 PM CST
Arich Enterprise Market Cap
Arich Enterprise has a market cap or net worth of 1.35 billion as of July 14, 2026. Its market cap has decreased by -22.70% in one year.
Market Cap
1.35B
Enterprise Value
1.00B
Revenue
1.56B
Ranking
n/a
PE Ratio
17.41
Stock Price
17.95
Market Cap Chart
Since July 10, 2012, Arich Enterprise's market cap has increased from 863.24M to 1.35B, an increase of 55.93%. That is a compound annual growth rate of 3.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 1.34B | -14.93% |
| Dec 31, 2025 | 1.57B | -4.09% |
| Dec 31, 2024 | 1.64B | 0.23% |
| Dec 29, 2023 | 1.64B | 13.44% |
| Dec 30, 2022 | 1.44B | 7.50% |
| Dec 30, 2021 | 1.34B | -28.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 515.30B |
| Caliway Biopharmaceuticals | 167.31B |
| Heron Neutron Medical | 68.67B |
| Pell Bio-Med Technology | 59.93B |
| GeneFerm Biotechnology | 1.43B |
| GenMont Biotech Incorporation | 1.41B |
| Andros Pharmaceuticals Co.,Ltd | 1.41B |
| Bioptik Technology Incorporation | 1.38B |